tiprankstipranks
Trending News
More News >
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX

Compare Pacira Pharmaceuticals (PCRX) vs. Competitors

Compare
380 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Pacira Pharmaceuticals
$20.65
$888.39M
42.95
-5.62%
4 Buy
2 Hold
1 Sell
Moderate Buy
Avadel Pharmaceuticals
$21.48
$2.10B
-3,905.45
163.24%
0 Buy
10 Hold
0 Sell
Hold
Supernus Pharmaceuticals
$50.26
$2.88B
-146.71
31.19%
5 Buy
1 Hold
0 Sell
Strong Buy
ANI Pharmaceuticals
$85.29
$1.92B
52.02
50.82%
3 Buy
1 Hold
0 Sell
Strong Buy
Amphastar Pharmaceuticals
$26.00
$1.19B
11.56
-28.26%
2 Buy
3 Hold
0 Sell
Moderate Buy
Collegium Pharmaceutical
$46.90
$1.48B
28.38
42.29%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PCRX
Pacira Pharmaceuticals
20.65
-1.71
-7.65%
AVDL
Avadel Pharmaceuticals
21.48
13.73
177.16%
SUPN
Supernus Pharmaceuticals
50.26
12.52
33.17%
ANIP
ANI Pharmaceuticals
85.29
26.83
45.89%
AMPH
Amphastar Pharmaceuticals
26.00
-9.70
-27.17%
COLL
Collegium Pharmaceutical
46.90
13.55
40.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts